The luteal phase after GnRH-agonist triggering of ovulation: Present and future perspectives

Reproductive BioMedicine Online

Volumn 24, Issue 2, 2012, Pages 134-141

  Humaidan, Peter ^a   Papanikolaou, E G ^b   Kyrou, D ^b   Alsbjerg, B ^c   Polyzos, N P ^d   Devroey, P ^e   Fatemi, Human M ^e  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c SKIVE REGIONAL HOSPITAL   (Denmark)

^d Panhellenic Association for Continual Medical Research PACMeR   (Greece)

^e VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

GnRH agonist; GnRH antagonist; HCG; IVF; luteal phase; ovulation induction

Indexed keywords

CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; ESTRADIOL; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; LUTEINIZING HORMONE; NALOXONE; OPIATE ANTAGONIST; PROGESTERONE; RECOMBINANT LUTEINIZING HORMONE;

FERTILIZATION IN VITRO; HUMAN; HYPOPHYSIS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INTRACYTOPLASMIC SPERM INJECTION; LUTEAL PHASE; LUTEINIZING HORMONE RELEASE; NEGATIVE FEEDBACK; OOCYTE MATURATION; OVARY HYPERSTIMULATION; OVULATION; OVULATION INDUCTION; PREGNANCY RATE; REVIEW;

BUSERELIN; CHORIONIC GONADOTROPIN; CLOMIPHENE; EMBRYO IMPLANTATION; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; LUTEAL PHASE; LUTEINIZING HORMONE; NARCOTIC ANTAGONISTS; OOCYTE RETRIEVAL; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; PREGNANCY;

EID: 84856667547     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2011.11.001     Document Type: Review

References (83)

1. C. Albano, J. Smitz, M. Camus, H. Riethmüller-Winzen, A. Van Steirteghem, and P. Devroey Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation Fertil. Steril. 67 1997 917 922 (Pubitemid 27183922)
2. C. Albano, G. Grimbizis, J. Smitz, H. Riethmuller-Winzen, T. Reissmann, A. Van Steirteghem, and P. Devroey The luteal phase of nonsupplemented cycles after ovarian superovulation with human menopausal gonadotropin and the gonadotropin-releasing hormone antagonist Cetrorelix Fertil. Steril. 70 1998 357 359 (Pubitemid 28361495)
3. R. Babayof, E.J. Margalioth, M. Huleihel, A. Amash, E. Zylber-Haran, M. Gal, B. Brooks, T. Mimoni, and T. Eldar-Geva Serum Inhibin A, VEGF and TNFα levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial Hum. Reprod. 21 2006 1260 1265
4. J. Balasch, F. Fabregues, R. Tur, M. Creus, R. Casamitjana, J. Peñarrubia, P.N. Barri, and J.A. Vanrell Further characterization of the luteal phase inadequacy after gonadotrophin-releasing hormone agonist-induced ovulation in gonadotrophin-stimulated cycles Hum. Reprod. 10 1995 1377 1381
5. N.G. Beckers, N.S. Macklon, M.J. Eijkemans, M. Ludwig, R.E. Felberbaum, K. Diedrich, S. Bustion, E. Loumaye, and B.C. Fauser Non supplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment J. Clin. Endocrinol. Metab. 88 2003 4186 4192 (Pubitemid 37158033)
6. M.L. Bonduelle, R. Dodd, I. Liebaers, A. Van Steirteghem, R. Williamson, and R. Akhurst Chorionic gonadotrophin-beta mRNA, a trophoblast marker, is expressed in human 8-cell embryos derived from tripronucleate zygotes Hum. Reprod. 3 1988 909 914
7. G. Borm, and B. Mannaerts Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group Hum. Reprod. 15 2000 1490 1498
8. C. Bourgain, F. Ubaldi, A. Tavaniotou, J. Smitz, A.C. Van Steirteghem, and P. Devroey Endometrial hormone receptors and proliferation index in the periovulatory phase of stimulated embryo transfer cycles in comparison with natural cycles and relation to clinical pregnancy outcome Fertil. Steril. 78 2002 237 244 (Pubitemid 34845894)
9. A.E. Cantineau, B.J. Cohlen, and M.J. Heineman Ovarian stimulation protocols (anti-oestrogens, gonadotrophins with and without GnRH agonists/antagonists) for intrauterine insemination (IUI) in women with subfertility Cochrane Database Syst. Rev. 18 2007 CD005356
10. R.F. Casper, and S.S. Yen Induction of luteolysis in the human with a long-acting analog of luteinizing hormone-releasing factor Science 205 1979 408 410 (Pubitemid 9243922)
11. L. Dal Prato, and A. Borini Use of antagonists in ovarian stimulation protocols Reprod. Biomed. Online 10 2005 330 338 (Pubitemid 40372664)
12. M.D. Damewood, W. Shen, H.A. Zacur, W.D. Schlaff, J.A. Rock, and E.E. Wallach Disappearance of exogenously administered human chorionic gonadotropin Fertil. Steril. 52 1989 398 400 (Pubitemid 19228282)
13. D. De Ziegler, C. Cornel, C. Bergeron, A. Hazout, P. Bouchard, and R. Frydman Controlled preparation of the endometrium with exogenous estradiol and progesterone in women having functioning ovaries Fertil. Steril. 56 1991 851 855
14. L. Devoto, M. Vega, P. Kohen, A. Castro, O. Castro, L.K. Christenson, P. Carvallo, and J.F. Strauss 3rd Endocrine and paracrine-autocrine regulation of the human corpus luteum during the mid-luteal phase J. Reprod. Fertil. 2000 13 20
15. R.P. Dickey, and D.E. Holtkamp Development, pharmacology and clinical experience with clomiphene citrate Hum. Reprod. Update 2 1996 483 550
16. D.M. Duffy, D.R. Stewart, and R.L. Stouffer Titrating luteinizing hormone replacement to sustain the structure and function of the corpus luteum after gonadotropin-releasing hormone antagonist treatment in rhesus monkeys J. Clin. Endocrinol. Metab. 84 1999 342 349 (Pubitemid 29036724)
17. R.G. Edwards, P.C. Steptoe, and J.M. Purdy Establishing full-term human pregnancies using cleaving embryos grown in vitro Br. J. Obstet. Gynaecol. 87 1980 737 756 (Pubitemid 10009721)
18. L. Engmann, A. DiLuigi, D. Schmidt, J. Nulsen, D. Maier, and C. Benadiva The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomised controlled study Fertil. Steril. 89 2008 84 91
19. J.J. Eppig FSH stimulates hyaluronic acid synthesis by oocyte-cumulus complexes from mouse preovulatory follicle Nature 281 1979 483 484 (Pubitemid 10244270)
20. R. Fanchin, E. Peltier, R. Frydman, and D. de Ziegler Human chorionic gonadotropin: does it affect human endometrial morphology in vivo? Semin. Reprod. Med. 19 2001 31 35 (Pubitemid 32489043)
21. H.M. Fatemi The luteal phase after 3 decades of IVF: what do we know? Reprod. Biomed. Online 19 2009 4331
22. H.M. Fatemi, D. Kyrou, C. Bourgain, E. Van den Abbeel, G. Griesinger, and P. Devroey Cryopreserved-thawed human embryo transfer: spontaneous natural cycle is superior to human chorionic gonadotropin-induced natural cycle Fertil. Steril. 94 2010 2054 2058
23. B.C. Fauser, and P. Devroey Reproductive biology and IVF: ovarian stimulation and luteal phase consequences Trends Endocrinol. Metab. 14 2003 236 242 (Pubitemid 36841482)
24. M. Filicori, N. Santoro, G.R. Merriam, and W.F. Crowley Jr. Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle J. Clin. Endocrinol. Metab. 62 1986 1136 1144 (Pubitemid 16085272)
25. R. Forman, N. Fries, J. Testart, J. Belaisch-Allart, A. Hazout, and R. Frydman Evidence for an adverse effect of elevated serum estradiol concentrations on embryo implantation Fertil. Steril. 49 1988 118 122 (Pubitemid 18033903)
26. J.A. Garcia-Velasco, L. Motta, A. López, M. Mayoral, M. Cerrillo, and A. Pacheco Low-dose human chorionic gonadotropin versus estradiol/ progesterone luteal phase support in gonadotropin-releasing hormone agonist-triggered assisted reproductive technique cycles: understanding a new approach Fertil. Steril. 94 2010 2820 2823
27. Y. Gonen, H. Balakier, W. Powell, and R.F. Casper Use of GnRH agonist to trigger follicular maturation for in vitro fertilization J. Clin. Endocrinol. Metab. 71 1990 918 922
28. R.V. Haning Jr., E.Y. Strawn, and W.E. Nolten Pathophysiology of the ovarian hyperstimulation syndrome Obstet. Gynecol. 66 1985 220 224 (Pubitemid 15049726)
29. J.D. Hoff, M.E. Quigley, and S.S. Yen Hormonal dynamics at midcycle: a reevaluation J. Clin. Endocrinol. Metab. 57 1983 792 796 (Pubitemid 13013538)
30. P. Humaidan, H.E. Bredkjaer, L. Bungum, M. Bungum, M.L. Grøndahl, L. Westergaard, and C.Y. Andersen GnRH agonist (Buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomised study Hum. Reprod. 20 2005 1213 1220 (Pubitemid 40796107)
31. P. Humaidan, L. Bungum, M. Bungum, and C.Y. Andersen Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study Reprod. Biomed. Online 13 2006 173 178 (Pubitemid 44207763)
32. P. Humaidan, H.E. Bredkjaer, L.G. Westergaard, and C.Y. Andersen 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study Fertil. Steril. 93 2010 847 854
33. P. Humaidan Luteal phase rescue in high-risk OHSS patients by GnRHa triggering in combination with low-dose HCG: a pilot study Reprod. Biomed. Online 18 2009 630 634
34. D.A. Imoedemhe, A.B. Sigue, E.L. Pacpaco, and A.B. Olazo Stimulation of endogenous surge of luteinizing hormone with gonadotropin-releasing hormone analog after ovarian stimulation for in vitro fertilization Fertil. Steril. 55 1991 328 332
35. J. Itskovitz, R. Boldes, J. Levron, Y. Erlik, L. Kahana, and J.M. Brandes Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist Fertil. Steril. 56 1991 213 220
36. J. Itskovitz-Eldor, S. Kol, B. Mannaerts, and H.C. Bennink First established pregnancy after controlled ovarian hyperstimulation with recombinant follicle stimulating hormone and the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) Hum. Reprod. 13 1998 294 295
37. J.F. Kerin, T.J. Broom, M.M. Ralph, D.K. Edmonds, G.M. Warnes, R. Jeffrey, J.M. Crocker, B. Godfrey, L.W. Cox, R.F. Seamark, and C.D. Matthews Human luteal phase function following oocyte aspiration from the immediately preovular graafian follicle of spontaneous ovular cycles Br. J. Obstet. Gynaecol. 88 1981 1021 1028 (Pubitemid 11028072)
38. M.J. Kessler, M.S. Reddy, R.H. Shah, and O.P. Bahl Structure of N-glycosidic carbohydrate units of human chorionic gonadotropin J. Biol. Chem. 254 1979 7901 7908 (Pubitemid 10233617)
39. S. Kol Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome Fertil. Steril. 81 2004 1 5 (Pubitemid 38058315)
40. S. Kol, and P. Humaidan LH (as HCG) and FSH surges for final oocyte maturation: sometimes it takes two to tango? Reprod. Biomed. Online 21 2010 590 592
41. S. Kol, P. Humaidan, and J. Itskovitz-Eldor GnRH agonist ovulation trigger and hCG-based, progesterone-free luteal support: a proof of concept study Hum. Reprod. 26 2011 2874 2877
42. S. Kol, and J. Itskovitz-Eldor Severe OHSS: yes there is a strategy to prevent it! Hum. Reprod. 15 2000 2266 2267
43. E. Kolibianakis, C. Bourgain, C. Albano, K. Osmanagaoglu, J. Smitz, A. Van Steirteghem, and P. Devroey Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up Fertil. Steril. 78 2002 1025 1029 (Pubitemid 35292504)
44. S.Y. Ku, Y.M. Choi, C.S. Suh, S.H. Kim, J.G. Kim, S.Y. Moon, and J.Y. Lee Effect of gonadotropins on human endometrial stromal cell proliferation in vitro Arch. Gynecol. Obstet. 266 2002 223 228 (Pubitemid 36056598)
45. C.B. Lambalk, and R. Homburg GnRH agonist for luteal support in IVF? Setting the balance between enthusiasm and caution Hum. Reprod. 21 2006 2580 2582 (Pubitemid 44542148)
46. A. Lewin, G. Pisov, R. Turgeman, M. Fatum, Y. Shufaro, A. Simon, N. Laufer, A. Revel, B. Reubinoff, and A. Safran Simplified artificial endometrial preparation, using oral estradiol and novel vaginal progesterone tablets: a prospective randomized study Gynecol. Endocrinol. 16 2002 131 136 (Pubitemid 34496879)
47. P. Licht, V. Russu, and L. Wildt On the role of human chorionic gonadotropin (hCG) in the embryo-endometrial microenvironment: implications for differentiation and implantation Semin. Reprod. Med. 19 2001 37 47 (Pubitemid 32489044)
48. P. Licht, V. Russu, S. Lehmeyer, and L. Wildt Molecular aspects of direct LH/hCG effects on human endometrium - lessons from intrauterine microdialysis in the human female in vivo Reprod. Biol. 1 2001 10 19
49. B.M. Mannaerts, T.B. Geurts, and J. Odink A randomized three-way crossover study in healthy pituitary-suppressed women to compare the bioavailability of human chorionic gonadotrophin (Pregnyl) after intramuscular and subcutaneous administration Hum. Reprod. 13 1998 1461 1464 (Pubitemid 28310473)
50. M. Maruncic, and R.F. Casper The effect of luteal phase estrogen antagonism on luteinizing hormone pulsatility and luteal function in women J. Clin. Endocrinol. Metab. 64 1987 148 152 (Pubitemid 17015892)
51. C.R. McCartney, C.A. Eagleson, and J.C. Marshall Regulation of gonadotropin secretion: implications for polycystic ovary syndrome Semin. Reprod. Med. 20 2002 317 326
52. A. Miyake, T. Aono, T. Kinugasa, O. Tanizawa, and K. Kurachi Suppression of serum levels of luteinizing hormone by short- and long-loop negative feedback in ovariectomized women J. Endocrinol. 80 1979 353 356 (Pubitemid 9142291)
53. P.A. Nepomnaschy, C.R. Weinberg, A.J. Wilcox, and D.D. Baird Urinary hCG patterns during the week following implantation Hum. Reprod. 23 2008 271 277 (Pubitemid 351651264)
54. J.J. Oberyé, B.M. Mannaerts, H.J. Kleijn, and C.J. Timmer Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran): Part I. Absolute bioavailability of 0.25 mg of ganirelix after a single subcutaneous injection in healthy female volunteers Fertil. Steril. 72 1999 1001 1005
55. K. Oktay, I. Türküolu, and K.A. Rodriguez-Wallberg GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation Reprod. Biomed. Online 20 2010 783 788
56. R. Orvieto Can we eliminate ovarian hyperstimulation syndrome? Hum. Reprod. 20 2005 320 322 (Pubitemid 40277597)
57. E.G. Papanikolaou, C. Pozzobon, E.M. Kolibianakis, M. Camus, H. Tournaye, H. Fatemi, A. Van Steirteghem, and P. Devroey Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles Fertil. Steril. 85 2006 112 120 (Pubitemid 43063432)
58. E.G. Papanikolaou, W. Verpoest, H. Fatemi, B. Tarlatzis, P. Devroey, and H. Tournaye A novel method of luteal supplementation with recombinant luteinizing hormone when a gonadotropin-releasing hormone agonist is used instead of human chorionic gonadotropin for ovulation triggering: a randomized prospective proof of concept study Fertil. Steril. 95 2011 1174 1177
59. C. Pirard, J. Donnez, and E. Loumaye GnRH agonist as luteal phase support in assisted reproduction technique cycles: results of a pilot study Hum. Reprod. 21 2006 1894 1900 (Pubitemid 44028266)
60. R.N. Porter, W. Smith, I.L. Craft, N.A. Abdulwahid, and H.S. Jacobs Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins Lancet 2 1984 1284 1285 (Pubitemid 15217748)
61. C.V. Rao Multiple novel roles of luteinizing hormone Fertil. Steril. 76 2001 1097 1100 (Pubitemid 33116369)
62. E. Reshef, Z.M. Lei, C.V. Rao, D.D. Pridham, N. Chegini, and J.L. Luborsky The presence of gonadotropin receptors in nonpregnant human uterus, human placenta, fetal membranes, and decidua J. Clin. Endocrinol. Metab. 70 1990 421 430
63. S.M. Rosenberg, A.A. Luciano, and D.H. Riddick The luteal phase defect: the relative frequency of, and encouraging response to, treatment with vaginal progesterone Fertil. Steril. 34 1980 17 20 (Pubitemid 10035751)
64. W.G. Rossmanith, M. Monn, and R. Benz Effects of chronic opioid antagonism on gonadotrophin and ovarian sex steroid secretion during the luteal phase Clin. Endocrinol. 49 1998 343 351 (Pubitemid 28448945)
65. S. Segal, and R.F. Casper Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin for triggering follicular maturation in in vitro fertilization Fertil. Steril. 57 1992 1254 1258
66. B.S. Shapiro, S.T. Daneshmand, F.C. Garner, M. Aguirre, and S. Thomas Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization Fertil. Steril. 90 2008 231 233 (Pubitemid 351885203)
67. B.S. Shapiro, S.T. Daneshmand, F.C. Garner, M. Aguirre, and C. Hudson Comparison of 'triggers' using leuprolide acetate alone or in combination with low-dose human chorionic gonadotropin Fertil. Steril. 95 2011 2715 2717
68. M. Shemesh, D. Mizrachi, M. Gurevich, L.S. Shore, J. Reed, S.M. Chang, W.W. Thatcher, and M.J. Fields Expression of functional luteinizing hormone (LH) receptor and its messenger ribonucleic acid in bovine endometrium: LH augmentation of cAMP and inositol phosphate in vitro and human chorionic gonadotropin (hCG) augmentation of peripheral prostaglandin in vivo Reprod. Biol. 1 2001 13 32
69. J. Smitz, P. Devroey, B. Faguer, C. Bourgain, M. Camus, and A.C. Van Steirteghem A randomized prospective study comparing supplementation of the luteal phase and early pregnancy by natural progesterone administered by intramuscular or vaginal route Rev. Fr. Gynecol. Obstet. 87 1992 507 516 (Pubitemid 23002216)
70. J. Smitz, P. Erard, M. Camus, P. Devroey, H. Tournaye, A. Wisanto, and A.C. Van Steirteghem Pituitary gonadotrophin secretory capacity during the luteal phase in superovulation using GnRH-agonists and HMG in a desensitization or flare-up protocol Hum. Reprod. 7 1992 1225 1229
71. S. Stickland, and W. Beers Studies on the role of plasminogen activator in ovulation. In vitro response of granulosa cells to gonadotrophins, cyclic nucleotides and prostaglandins J. Biol. Chem. 251 1976 5694 5702
72. N. Sugino, S. Kaskida, S. Takiguchi, A. Karube, and H. Kato Expression of vascular endothelial growth factor and its receptors in the human corpus luteum during the menstrual cycle and in early pregnancy J. Clin. Endocrinol. 85 2000 3919 3924
73. B.C. Tarlatzis, B.C. Fauser, E.M. Kolibianakis, K. Diedrich, L. Rombauts, and P. Devroey GnRH antagonists in ovarian stimulation for IVF Hum. Reprod. Update 12 2006 333 340 (Pubitemid 43932048)
74. A. Tavaniotou, and P. Devroey Effect of human chorionic gonadotropin on luteal luteinizing hormone concentrations in natural cycles Fertil. Steril. 80 2003 654 655 (Pubitemid 37102887)
75. A. Tavaniotou, C. Albano, J. Smitz, and P. Devroey Comparison of LH concentrations in the early and mid-luteal phase in IVF cycles after treatment with HMG alone or in association with the GnRH antagonist Cetrorelix Hum. Reprod. 16 2001 663 667 (Pubitemid 32293792)
76. J. Tesarik, A. Hazout, and C. Mendoza Luteinizing hormone affects uterine receptivity independently of ovarian function Reprod. Biomed. Online 7 2003 59 64 (Pubitemid 36874407)
77. F. Ubaldi, C. Bourgain, H. Tournaye, J. Smitz, A. Van Steirteghem, and P. Devroey Endometrial evaluation by aspiration biopsy on the day of oocyte retrieval in the embryo transfer cycles in patients with serum progesterone rise during the follicular phase Fertil. Steril. 67 1997 521 526 (Pubitemid 27085969)
78. D. Valbuena, J. Martin, J.L. de Pablo, J. Remohí, A. Pellicer, and C. Simón Increasing levels of estradiol are deleterious to embryonic implantation because they directly affect the embryo Fertil. Steril. 76 2001 962 968 (Pubitemid 33031323)
79. T.H. Wang, S.G. Horng, C.L. Chang, H.M. Wu, Y.J. Tsai, H.S. Wang, and Y.K. Soong Human chorionic gonadotropin-induced hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor J. Clin. Endocrinol. Metab. 87 2002 3300 3308
80. C. Yding Andersen Effect of FSH and its different isoforms on maturation of oocytes from pre-ovulatory follicles Reprod. Biomed. Online 5 2002 232 239
81. C. Yding Andersen, L. Leonardsen, A. Ulloa-Aguirre, J. Barrios-De-Tomasi, L. Moore, and A.G. Byskov FSH-induced resumption of meiosis in mouse oocytes: effect of different isoforms Mol. Hum. Reprod. 5 1999 726 731 (Pubitemid 29366869)
82. M.B. Zelinski-Wooten, J.S. Hutchison, D.L. Hess, D.P. Wolf, and R.L. Stouffer Follicle stimulating hormone alone supports follicle growth and oocyte development in gonadotrophin-releasing hormone antagonist-treated monkeys Hum. Reprod. 10 1995 1658 1666
83. A.J. Ziecik, K. Derecka-Reszka, and S.J. Rzucidło Extragonadal gonadotropin receptors, their distribution and function J. Physiol. Pharmacol. 43 1992 33 49